Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from NexGel Inc ( (NXGL) ) is now available.
On December 11, 2025, NEXGEL, Inc. announced the spin-off of its drug delivery program into a new entity, NexGelRx, which will focus on developing prescription drug delivery solutions using NEXGEL’s proprietary hydrogel technology. As part of the spin-off, NEXGEL shareholders will receive a 19.99% equity interest in NexGelRx and a 5% global royalty on products sold using its technology. This move allows NEXGEL to concentrate on its core business areas while potentially unlocking significant value for its shareholders.
The most recent analyst rating on (NXGL) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on NexGel Inc stock, see the NXGL Stock Forecast page.
Spark’s Take on NXGL Stock
According to Spark, TipRanks’ AI Analyst, NXGL is a Neutral.
NexGel Inc’s overall stock score is primarily impacted by its financial performance, which shows strong revenue growth but persistent net losses and negative cash flows. Technical analysis indicates bearish momentum, further weighing on the score. Valuation concerns with a negative P/E ratio highlight ongoing profitability challenges. The earnings call provided some positive guidance and strategic initiatives, but uncertainties and flat revenue growth remain significant risks.
To see Spark’s full report on NXGL stock, click here.
More about NexGel Inc
NEXGEL, Inc. is a leading provider of healthcare, beauty, and over-the-counter products, specializing in ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pennsylvania, the company has a history of developing electron-beam, cross-linked hydrogels and maintains strategic contract manufacturing relationships with prominent consumer healthcare companies.
Average Trading Volume: 65,324
Technical Sentiment Signal: Sell
Current Market Cap: $16.41M
Learn more about NXGL stock on TipRanks’ Stock Analysis page.